Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 6-week Safety and Efficacy Study of Combination IOP-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension.

NCT00051194 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00051194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00051194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 6-week Safety and Efficacy Study of Combination IOP-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension.
Lead sponsor
Alcon Research
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2002
Completion date
July 31, 2003
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open-angle, ocular hypertension